ABCC8 and familial pancreatic carcinoma: These findings are in line with the omics and literature data on the role of ABCC8/Sur1 that was found downregulated in pancreatic cancer (Mohelnikova-Duchonova et al., 2013), where the low expression of ABCC8 is associated with poor prognosis with drug–disease interaction.